BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  FDA

  At Last, FDA Signs Off on Adamis’ Opioid Overdose Drug

  Zimhi is indicated for use in both adults and children in the event of an emergency. It is to be given right away and does not take the place of emergency care.

  October 19, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Another Milestone: LogicBio Successfully Edits Genes in Children

  On Monday, LogicBio Therapeutics unveiled clinical trial results demonstrating the first-ever in vivo, nuclease-free genome editing in little humans.

  October 19, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Genetown

  Is mRNA the Future of Drug Development?

  The idea of using mRNA has been around for some time, but only in recent years has it become practical. The COVID-19 pandemic provided the opportunity for the technology to push ahead.

  October 19, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  CAR-T Pioneer Carl June Will Lend Wisdom to Bioheng Biotech

  June really broke out in 2012 when he saved the life of Emily Whitehead, a child suffering from relapsed acute lymphoblastic leukemia (ALL), with CD19 CAR-T.

  October 19, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Job Trends

  Life Sciences Industry in California Defies Pandemic-Driven Employment Downturn

  Although California is already a well-known hotbed for science and technology, the pandemic still precipitated a surge of activity in the life sciences industry.

  October 19, 2021

   · 

  3 min read

   · 

  Kaylei Whalen
• 

  Drug Development

  COVID-19 and the Spanish Flu - Drawing Comparisons

  With the Delta variant of coronavirus spreading globally, the pandemic still has a tight grip on the world. Many people around globe are struggling to come to terms with the aftermath of the pandemic, much like a century ago with the Spanish flu.

  October 19, 2021

   · 

  7 min read

   · 

  Mishayl Hanan
• 

  Drug Development

  Calithera Biosciences Scores Two Complementary Oncology Compounds in Takeda Deal

  Calithera Biosciences is expanding its oncology portfolio with the addition of two clinical-stage compounds from Takeda Pharmaceuticals.

  October 19, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Crinetics Pharma Spinout Launches with Sight Set on Radiopharmaceuticals

  Crinetics Pharmaceuticals, along with 5AM Ventures and Frazier Healthcare Partners, announced that it was spinning out a new company, Radionetics Oncology.

  October 19, 2021

   · 

  2 min read

   · 

  Ellen Camacho
• 

  Drug Development

  Lilly’s Longest Diabetes Drug Trial Lowers A1C and Increases Weight Loss

  SURPASS-4 is part of the Phase III trial evaluating tirzepatide as a possible treatment for type 2 diabetes.

  October 19, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Roche-Partnered COVID-19 Antiviral Flunks in Phase II

  AT-527, an oral direct-acting antiviral agent that blocks viral RNA polymerase needed for viral replication, failed to meet its primary endpoint in the Phase II MOONSONG study.

  October 19, 2021

   · 

  2 min read

   · 

  Alex Keown